RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.

Rodney Snyder
Experts

Rodney Snyder

Senior Research Chemist

Education

MS, Nutrition Science, Pennsylvania State University
BS, Life Science, Pennsylvania State University

Connect

Rodney Snyder is a senior research chemist at RTI. He has over 30 years of experience in bioanalytical analysis and pharmacokinetics, as well as exposure assessment by DNA/protein-adduct measurement and biomarker determination. Mr. Snyder is an expert at developing hemoglobin and DNA-adduct assays for exposure assessment of high-production chemicals. He uses high-resolution mass spectrometry to characterize the metabolism of chemicals and therapeutic agents and untargeted  analysis of biological samples to determine exposure to emerging and prominent chemicals. 

Mr. Snyder’s recently research activities include the untargeted analysis of PFAS in formulations and biological samples to assess exposure and bioaccumulation. Mr. Snyder investigates potential therapeutic compounds and their ability to cross the blood-brain barrier, metabolite identification, and untargeted analysis of combined exposures and mixtures. 

In addition to his work, Mr. Snyder is a member of the Society of Toxicology. 

Expertise
  • Biomarkers
  • Pharmacokinetics
  • Metabolite identification
  • Untargeted analysis

Publications

View All Publications
Article

Untargeted lipidomics reveals novel HDL metabotypes and lipid-clinical correlates

December 2024
Article

Isoquinolone derivatives as lysophosphatidic acid receptor 5 (LPA5) antagonists: Investigation of structure-activity relationships, ADME properties and analgesic effects

December 2022
Article

Neuropeptide B/W receptor 1 peptidomimetic agonists: Structure-activity relationships and plasma stability

March 2022
Article

Intravenous administration of three multiwalled carbon nanotubes to female rats and their effect on urinary biochemical profile

March 2022

Related Capabilities

Focus Area

PFAS Research
Solution

Drug Metabolism and Pharmacokinetics (DMPK)

Get in Touch

To speak to this expert or inquire about RTI services, you can reach us at +1 919 541 6000 or use the contact form below. For media inquiries, please reach out to our Media Relations team at news@rti.org.

Blue background circle graphics